S&P 500: 1,317.11 Change: -0.21%

rjm77me

P&P Score: 99.94 Points: 616.65 Accuracy: 77.28% Average Pick Score: 0.89 Annual Return: 32.85% (94.05% since 7/16/09)

rjm77me's Blog : Affymax Inc. (AFFY)

December 7, 2011

Comments (1) Rate this post

Recommend This Post (62) Abuse this post

Report Abuse

Share This

Affymax Inc. (AFFY) won a U.S. panel’s backing for an experimental anemia medicine that would compete with treatments marketed by Amgen Inc. (AMGN) and Johnson & Johnson (JNJ) for patients with chronic kidney disease.

The benefits of the drug, known as peginesatide, outweigh potential heart risks, outside advisers to the Food and Drug Administration said today in a 15-1 vote in Silver Spring, Maryland. The FDA isn’t required to follow the advisory panels’recommendations

One more step to go before it hits the jackpot

Tags : AFFY AMGN JNJ

1 Comment(s):

rjm77me

December 7, 2011 17:41 Abuse this post

Report Abuse

GII is another which is going to pop up after hours and tomorrow morning

Want to comment on this post? Sign up now. It's FREE!
Already registered? Log In.

Sponsored Links

Make Big Bucks promoting Zacks products on your website! Click here to Learn about Zacks' Affiliate program.

Zacks Top Ten Stocks for 2011 are now available! This 10-stock portfolio is a well-balanced mix of aggressive and conservative, large and small cap, growth and value. Buy them. Hold them. Watch your gains add up

Take advantage of quick short-term moves, and profit from price moves in any direction. Trade options under the direction of an expert guide. Try it now and get a 90-day unconditional money-back guarantee. 50% OFF for a limited time! Zacks Options Trader >>

Find Winning Stocks Quickly with Research Wizard, a powerful desktop software program. Start with easy-to-use pre-loaded strategies, then develop your own. Backtest against years of historical data to see how your approach works in any market. Start a Free Trial Today >>